Systematic review with meta-analysis: the impact of functional cure on clinical outcomes in patients with chronic hepatitis B.

HBsAg loss is associated with a reduced risk of clinical outcomes. However, several shortcomings in the published studies prevent a more definitive conclusion on the potential benefits of HBsAg loss.